F11a and FX12a Inhibitors – the Next Wave of Novel Anticoagulants?
Anticoagulation treatment has been revolutionised in the past few decades with the development of drugs that increasingly target individual components of the coagulation cascade. Yet the quest to find improved […]
Time is Right for Restrictive Transfusion Strategy in ECMO
Despite studies supporting a restrictive red cell transfusion strategy in many medical situations, a more liberal strategy is still widely used in patients who need extracorporeal membrane oxygenation (ECMO), Alexander […]
Measuring the Success of PBM in Practice – Lessons from Spain
According to the World Health Organisation, widespread implementation of patient blood management (PBM) programmes remains an urgent need.1 It is also important to evaluate how well they are working, says […]
Meta-Analysis Backs up TXA Safety in Patients at Risk of Thrombosis
Tranexamic acid (TXA) is safe to use to prevent bleeding in patients at the time of surgery, even in those at risk of thrombosis, according to Patrick Meybohm (University Hospital […]
Diversity of PBM Reflected in Scientific Programme
There will be something for everyone in this year’s Scientific Programme, according to Sigismond Lasocki (University Hospital Angers, France), the Chair of the Scientific Committee.
“We tried to have not only a diversity of topics but also a diversity of speakers – both in terms of their home countries and in terms of their medical specialities,” says Lasocki.
Return to In-Person Event as NATA Celebrates its 25 th Anniversary!
Opening the Symposium and welcoming you to Athens will be NATA Chair Jens Meier (Kepler University Hospital, Linz, Austria). Meier will take a look at the evolution of PBM and how it has changed since NATA formed as an independent medical association in 1998. He will also highlight some of the changes that have occurred within NATA in the past couple of years.
Restrictive transfusion strategy after cardiac surgery.
Zeroual and colleagues report the results of a single-centre, single-blinded randomised controlled study of cardiac surgery patients comparing two strategies for transfusion of red blood cells. The control group followed […]
Obituary: Hans Gombotz (1948–2021)
After a long battle with cancer and in his 73rd year, Professor Hans Gombotz passed away on September 13, 2021. We are mourning over the loss of a brilliant scientist, […]
SARS-CoV-2 infection and venous thromboembolism after surgery: an international prospective cohort study.
Surgical patients may be at high risk of venous thromboembolism (VTE). SARS‐CoV‐2 infection has been shown to increase this risk. In this huge international, multicentre, prospective cohort study of elective and emergency […]
Viscoelastic haemostatic assay augmented protocols for major trauma haemorrhage (ITACTIC): a randomized, controlled trial.
Current approaches to trauma resuscitation focus on the timely control of bleeding and correction of trauma-induced coagulopathy using the administration of haemostatic therapy. Over the past decade, targeted and individualized […]
Preoperative intravenous iron to treat anaemia before major abdominal surgery (PREVENTT): a randomised, double-blind, controlled trial.
Perioperative iron – There is no easy answer Intravenous (IV) iron is a major cornerstone of every PBM programme. It has been shown in many clinical situations that IV iron […]
Routine venous thromboembolism prophylaxis may be inadequate in the hypercoagulable state of severe coronavirus disease 2019.
This observationnal study has included 240 consecutive patients with confirmed severe acute respiratory syndrome coronavirus 2 infection admitted to one of three hospitals. One-hundred nine critically ill COVID 19 patients admitted […]
Effect of hydroxyethyl starch vs saline for volume replacement therapy on death or postoperative complications among high-risk patients undergoing major abdominal surgery: the FLASH randomized clinical trial.
There are few drugs that have gone through such a rollercoaster ride as hydroxyethyl starch (HES). While shortly after its introduction the belief still prevailed that all types of volume […]
Fibrinogen concentrate to cardiac surgery patients with ongoing bleeding does not increase the risk of thromboembolic complications or death.
In this retrospective, observational study, Waldén et al. describe the occurrence of thromboembolic events and mortality in cardiac surgery patients, depending on whether the patient had received fibrinogen supplementation. The […]
Effects of iron isomaltoside vs ferric carboxymaltose on hypophosphatemia in iron-deficiency anemia: two randomized clinical trials.
This article describes a new physiology via the upregulation of FGF23 by ferric carboxymaltose (FCM) with subsequent development of hypophosphatemia. It provides a degree of caution with the long-term use […]